Evidence map›Paper›PMID 32741367›Full record

ReviewIsrael journal of health policy research2020

Tuberculosis treatment outcomes of non-citizen migrants: Israel compared to other high-income countries.

D Chemtob, E Ogum

Abstract readReview
In one paragraph

Review in Israel journal of health policy research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Genomic, phenotypic and demographic characterization ofFrontiers in cellular and infection microbiology · 2023
    Article
  3. Article
  4. Tuberculosis in elderly Australians: a 10-year retrospective review.Western Pacific surveillance and response journal : WPSAR
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

D ChemtobDepartment of Tuberculosis and AIDS, Ministry of Health, P.O.B. 1176, 944727, Jerusalem, Israel. daniel.chemtob@moh.gov.il.ORCID 0000-0002-2864-9982
E OgumBraun School of Public Health and Community Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn TB low incidence countries, the outcome of TB treatment among non-citizen migrants from endemic countries affects ability to eliminate TB. This study compares TB treatment outcomes among non-citizen migrants in select pre-elimination country based on their policies for non-citizen migrant TB patients in order to determine how policy affects TB outcomes.

methodsA literature review was conducted via PUBMED, MEDLINE (2000-2017) on TB policy among non-citizen migrants and treatment outcome. Treatment outcome among migrants diagnosed in Israel during 2000-2014 was analysed.

resultsIn total, 18 publications met the inclusion criteria. All the countries reviewed except the United States offered free TB treatment to undocumented migrants. Successful TB treatment outcome for non-citizen migrants in Israel was 87%, the Netherlands was 90.7%, the UK was 82.1%, and outcomes in the US and Australia were not published.

conclusionsThere is a need to standardize results based on international definitions of migrants, asylum seekers, and refugees in order to determine status-specific barriers and to facilitate international comparisons. Policies insuring free access to TB care for non-citizen migrants are an important element for TB elimination in low incidence countries.

Indexed as

Health PolicyTransients and MigrantsDeveloped CountriesHealth Services AccessibilityHumansIncidenceIsraelRefugeesTreatment OutcomeTuberculosisComparative studyMigrant healthTuberculosis

Identifiers

PMID32741367
PMCPMC7397670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.